Delivery Order SPE2D021DA002-SPE2D325F398V
- Not listed
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received this contract award on August 13, 2025, with an ultimate completion date of August 18, 2025. The ceiling value for this delivery order is $1,636.62, and...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and will be performed at the...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $8,183.10 to DMS Pharmaceutical Group Inc. on August 1, 2025, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract carries no set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the Twinrix vaccine syringe. The delivery order has a potential value of $1,564.86 and a completion date of October 30, 2023. This order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency to supply various pharmaceutical and medical products to support...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the Twinrix vaccine syringe. The $2,347.29 contract has an August 23, 2023 completion date and was awarded on August 22, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products in support of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for Twinrix vaccine syringes valued at $1,636.62. The contract is firm fixed-price with an ultimate completion date of September 15, 2025, and was awarded on September 10, 2025. This delivery order was issued without set-aside designation and represents a specific pharmaceutical procurement...
- The Defense Logistics Agency Troop Support Medical awarded a $782 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Twinrix vaccine syringes. DMS will deliver the vaccines to a location in Park Ridge, Illinois by September 7th, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, ensuring supplies and equipment are available when and where needed to support military readiness and operations. This delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,454.93 on August 11, 2025, for the supply of Twinrix vaccine syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 by the Defense Logistics Agency's Medical Supply Chain division for TWINRIX vaccine syringes. The award, issued on July 21, 2025, with an ultimate completion date of July 24, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F398VDelivery Order
The Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. for Twinrix vaccine syringes valued at $2,454.93. The award, issued on September 9, 2025, with an ultimate completion date of September 12, 2025, carries firm fixed-price terms under a delivery order contract type with no set-aside designation. Performance will take place at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, executed this delivery order under its larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The company serves as a critical supplier in the federal pharmaceutical supply chain, distributing a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, biologics, vaccines, and medical consumables—to Department of Defense healthcare facilities nationwide. This Twinrix vaccine order represents a routine transactional execution within the broader SPE2DB program vehicle that enables the agency to procure medical supplies efficiently for military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/9/25 |